These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33162715)

  • 1. Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy.
    Gupta V; Sidhu M; Shah SN
    Asian J Transfus Sci; 2020; 14(1):83-86. PubMed ID: 33162715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of severe hemolytic disease of newborn due to alloimmunization in primigravida.
    Pandey P; Kumari S; Mandal S; Sawhney A; Jain R
    Transfus Clin Biol; 2023 Feb; 30(1):5-7. PubMed ID: 35944885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
    Jain A; Malhotra S; Marwaha N; Kumar P; Sharma RR
    Asian J Transfus Sci; 2018; 12(2):176-179. PubMed ID: 30692807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of antenatal alloimmunization in the southern districts of West Bengal and its significant associated factor.
    Naik A; Bhattacharya P; Das P; Mukherjee K; Mukhopadhyay P
    Asian J Transfus Sci; 2020; 14(2):119-125. PubMed ID: 33767537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of an Alloantibody against the Kell Blood Group Glycoprotein.
    Mattaloni SM; Arnoni C; Céspedes R; Nonaka C; Trucco Boggione C; Luján Brajovich ME; Trejo A; Zani N; Biondi CS; Castilho L; Cotorruelo CM
    Transfus Med Hemother; 2017 Jan; 44(1):53-57. PubMed ID: 28275334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic Disease of Fetus and Newborn in a Primigravida with Multiple Alloantibodies Involving Anti-Jk
    Iberahim S; Aizuddin MJ; Kadir NA; Rameli N; Adzahar S; Noor NHM; Abdullah WZ
    Oman Med J; 2020 Nov; 35(6):e206. PubMed ID: 33335745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population.
    Hassan MN; Mohd Noor NH; Johan Noor SR; Sukri SA; Mustafa R; Luc Aster HV
    Asian J Transfus Sci; 2014 Jul; 8(2):113-7. PubMed ID: 25161351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report.
    Yousuf R; Abdul Aziz S; Yusof N; Leong CF
    J Med Case Rep; 2012 Feb; 6():71. PubMed ID: 22348809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus and newborn mediated by anti-Di
    Jacobs JW; Abels E; Binns TC; Tormey CA; Sostin N
    Immunohematology; 2023 Apr; 39(1):32-34. PubMed ID: 37017601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
    Sidhu M; Bala R; Akhtar N; Sawhney V
    Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.
    Moinuddin I; Fletcher C; Millward P
    J Blood Med; 2019; 10():283-289. PubMed ID: 31692490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka.
    Mandal S; Malhotra S; Negi G; Tiwari A; Mitra S; Basu S; Singh P
    Immunohematology; 2020 Jun; 36(2):60-63. PubMed ID: 32667819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of alloantibodies associated with haemolytic disease of the fetus and newborn in pregnant women at the Ekiti State University Teaching Hospital, Ado-Ekiti, Southwest Nigeria.
    Olayanju AO; Chris NI; Emmanuel AE; Oyetunde AB; Adebisi KY; Okolo CS
    Afr J Reprod Health; 2023 Jun; 27(6s):70-78. PubMed ID: 37694704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic disease of the newborn due to anti-jkb: case report and review of the literature.
    Velasco Rodríguez D; Pérez-Segura G; Jiménez-Ubieto A; Rodríguez MA; Montejano L
    Indian J Hematol Blood Transfus; 2014 Jun; 30(2):135-8. PubMed ID: 24839369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.
    Pessoni LL; Ferreira MA; Silva JCRD; Alcântara KC
    Hematol Transfus Cell Ther; 2018; 40(4):326-331. PubMed ID: 30370410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.